The core domain of the p53 protein has been found to affect microRNA processing — its third known antitumour activity. Most cancerous p53 mutations affect this domain and may abolish all tumour-suppressor functions.
References
Toledo, F. & Wahl, G. M. Nature Rev. Cancer 6, 909–923 (2006).
Green, D. R. & Kroemer, G. Nature 458, 1127–1130 (2009).
Suzuki, H. I. et al. Nature 460, 529–533 (2009).
Ventura, A. & Jacks, T. Cell 136, 586–591 (2009).
He, L., He, X., Lowe, S. W. & Hannon, G. J. Nature Rev. Cancer 7, 819–822 (2007).
Lozano, G. Curr. Opin. Genet. Dev. 17, 66–70 (2007).
Suh, E.-K. et al. Nature 444, 624–628 (2006).
Bourdon, J.-C. et al. Genes Dev. 19, 2122–2137 (2005).
Whibley, C., Pharoah, P. D. P. & Hollstein, M. Nature Rev. Cancer 9, 95–107 (2009).
Vazquez, A., Bond, E. E., Levine, A. J. & Bond, G. L. Nature Rev. Drug Discov. 7, 979–987 (2008).
Vousden, K. H. & Lane, D. P. Nature Rev. Mol. Cell Biol. 8, 275–283 (2007).
Fuller-Pace, F. V. Nucleic Acids Res. 34, 4206–4215 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Toledo, F., Bardot, B. Three birds with one stone. Nature 460, 466–467 (2009). https://doi.org/10.1038/460466a
Published:
Issue Date:
DOI: https://doi.org/10.1038/460466a
- Springer Nature Limited
This article is cited by
-
Low tissue levels of miR-125b predict malignancy in solitary fibrous tumors of the pleura
Respiratory Research (2017)
-
Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway
Journal of Molecular Medicine (2010)